|
Search
Collections
Benchmarks
Upload document
Target
AD2 monoclonal antibodies
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
N9: Pilot study of novel shortened induction for high-risk neuroblastoma.
Org:
Memorial Sloan Kettering Cancer Center,
